Recent Press Releases

Emergent BioSolutions Receives Orphan Drug Designation for BioThrax for Post-Exposure Prophylaxis of Anthrax Disease

Emergent BioSolutions Receives Orphan Drug Designation for BioThrax for Post-Exposure Prophylaxis of Anthrax Disease ROCKVILLE, Md.--(BUSINESS WIRE)--April 21, 2014-- Emergent BioSolutions Inc....

Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project

Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project BEIJING, April 24, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading China-based vaccine...

URI & EpiVax scientists closer to designing vaccine for H. pylori pathogen

Providence, R.I. – Researchers from the University of Rhode Island are championing a recent breakthrough in the laboratory with the hopes it could lead to a vaccine against the pathogen...

Heat-stable vaccines urgently needed to reach the one in five children missed by immunisation worldwide

Geneva/Paris, 22 April 2014 – The need for vaccines to be kept constantly cold is proving a major barrier in improving poor immunisation coverage rates, with one in five children born each year...

GSK announces major 3-part transaction with Novartis to drive sustainable sales growth, improve long-term earnings and deliver increasing returns to shareholders

GSK announces major 3-part transaction with Novartis to drive sustainable sales growth, improve long-term earnings and deliver increasing returns to shareholders GlaxoSmithKline plc (LSE/NYSE:GSK)...

Novartis announces portfolio transformation, focusing company on leading businesses with innovation power and global scale: Pharmaceuticals, Eye Care and Generics

Novartis announces portfolio transformation, focusing company on leading businesses with innovation power and global scale: Pharmaceuticals, Eye Care and Generics Acquires GSK oncology products,...

NIH Funds Influenza Research and Surveillance Network

NIH Funds Influenza Research and Surveillance Network NIAID-Supported Centers Integrate Research to Improve Pandemic Preparedness Influenza scientists at five sites in the United States are to...

Gardasil® approved in the European Union for a 2-dose schedule in children aged from 9 to 13 years

A new 2-dose regimen for Gardasil®, quadrivalent HPV vaccine, now available for adolescents Lyon, France – April 7th 2014 – Sanofi Pasteur MSD announced today that the European...

Pitt CVR and Sanofi Pasteur Collaborate to Assess the Effectiveness of a Dengue Vaccine

Pitt CVR and Sanofi Pasteur Collaborate to Assess the Effectiveness of a Dengue Vaccine PITTSBURGH, April 15, 2014 – The University of Pittsburgh Center for Vaccine Research (CVR) and Sanofi...

NW BIO ANNOUNCES FINANCING OF UP TO $32 MILLION

NW BIO ANNOUNCES FINANCING OF UP TO $32 MILLION Funding Will Accelerate Expansion of European Manufacturing BETHESDA, Md., April 10, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: ...

Emergent BioSolutions Successfully Completes Pivotal Clinical Study to Support Expanded Indication for BioThrax

Emergent BioSolutions Successfully Completes Pivotal Clinical Study to Support Expanded Indication for BioThrax ROCKVILLE, Md.--(BUSINESS WIRE)--April 16, 2014-- Emergent BioSolutions Inc....

NIH Funds Influenza Research and Surveillance Network

NIH Funds Influenza Research and Surveillance Network NIAID-Supported Centers Integrate Research to Improve Pandemic Preparedness Wednesday, April 9, 2014 ​Influenza scientists at five sites...

Mucosis Announces a Strategic Partnership with Changchun Bcht Biotechnology of China and Raises Additional Capital

Mucosis Announces a Strategic Partnership with Changchun Bcht Biotechnology of China and Raises Additional Capital Groningen, the Netherlands, April 15, 2014 / B3C newswire / - Biotechnology company...

Mucosis Announces a Strategic Partnership with Changchun Bcht Biotechnology of China and Raises Additional Capital

Mucosis Announces a Strategic Partnership with Changchun Bcht Biotechnology of China and Raises Additional Capital Groningen, the Netherlands, April 15, 2014 / B3C newswire / - Biotechnology company...

Anuradha Gupta appointed Deputy CEO of the GAVI Alliance

Anuradha Gupta appointed Deputy CEO of the GAVI Alliance Geneva, 10 April 2014 - The GAVI Alliance is delighted to announce the appointment of Anuradha Gupta as its new Deputy CEO. With more...

Evolution of whooping cough bacterium could reduce vaccine effectiveness

The bacterium that causes whooping cough, Bordetella pertussis, has changed – most likely in response to the vaccine used to prevent the disease – with a possible reduced effectiveness of...

Dynavax Initiates Phase 3 Study of HEPLISAV-B(TM)

Dynavax Initiates Phase 3 Study of HEPLISAV-B(TM) BERKELEY, CA--(Marketwired - Apr 15, 2014) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced initiation of a new phase 3 clinical...

Novartis Vaccines appoints new Medical Affairs Director for North Europe

Novartis Vaccines appoints new Medical Affairs Director for North Europe 14 April 2014 – Novartis Vaccines is pleased to announce the appointment of Dr John Porter to the position of Medical...

Immunovaccine Highlights Enhanced Anti-Tumor Activity of Cancer Vaccine Combination Therapies in Presentation at the 2014 AACR Annual Meeting

Immunovaccine Highlights Enhanced Anti-Tumor Activity of Cancer Vaccine Combination Therapies in Presentation at the 2014 AACR Annual Meeting Study findings show enhanced therapeutic potential for...

Stemline Therapeutics Announces FDA Acceptance of IND for SL-701, a Synthetic Multi-Peptide Vaccine Targeting Glioma Brain Tumors

Stemline Therapeutics Announces FDA Acceptance of IND for SL-701, a Synthetic Multi-Peptide Vaccine Targeting Glioma Brain Tumors NEW YORK, Apr 08, 2014 (GLOBE NEWSWIRE via COMTEX) -- Stemline...